Stocks · Healthcare · Medical - Diagnostics & Research
Thermo Fisher Scientific Inc. TMO
$654.80 +0.35% Close, Oct 2, 2026 · NYSE · Market cap $242.11B
Low risk
Next earnings report: Oct 21, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 12 quarters (average surprise over the last four: +4.0%).
- Net debt is 3.5× EBITDA, a high level of leverage.
- The stock is in an uptrend: above its 200-day average for 51 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth46Neutral
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 46%
- EPS growth (TTM, YoY)Bottom 48%
- FCF growth (TTM, YoY)Top 44%
- Revenue growth, 3-year CAGRBottom 23%
- Revenue growth accelerationTop 29%
Quality58Neutral
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 20%
- Gross marginBottom 26%
- Operating marginTop 15%
- Cash conversion (OCF / net income)Bottom 36%
- Accruals (lower is better)Bottom 23%
- Net debt / EBITDA (lower is better)Bottom 25%
- Interest coverTop 24%
Value64Neutral
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 19%
- Free-cash-flow yieldTop 26%
- EBITDA / enterprise valueTop 27%
- Sales / enterprise valueBottom 43%
- P/E vs own 5-year history (lower is better)Bottom 22%
Momentum79Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 45%
- 6-month returnTop 29%
- 1-year return vs S&P 500Top 41%
- Distance from 52-week highTop 4%
- Trend checklist (0–4)Top 7%
Revisions64Neutral
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 49%
- Consecutive EPS beatsTop 4%
- Share of analysts rating BuyTop 37%
- Upside to consensus price targetBottom 9%
Stability81Strong
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 7%
- Maximum drawdown, 3 yearsTop 12%
- Beta vs S&P 500 (lower is better)Top 29%
- Net debt / EBITDA (lower is better)Bottom 25%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 5.4% | 7.2% | ↑ |
| EPS growth (YoY) | 6.7% | 7.6% | ↑ |
| Gross margin | 40.4% | 41.0% | ↑ |
| Operating margin | 18.4% | 18.0% | ↓ |
| FCF margin | 14.3% | 15.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 7.2% | 5.4% | ↑ | Bottom 46% |
| EPS growth (TTM, YoY) | 7.6% | 6.7% | ↑ | Bottom 48% |
| Gross margin | 41.0% | 40.4% | ↑ | Bottom 26% |
| Operating margin | 18.0% | 18.4% | ↓ | Top 15% |
| Net margin | 15.1% | 15.2% | ↓ | — |
| Free-cash-flow margin | 15.8% | 14.3% | ↑ | — |
| Return on invested capital | 7.6% | — | Top 20% | |
| Revenue growth, 3-year CAGR | -0.3% | — | Bottom 23% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.29×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -13.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.52×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 5.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.27%
- Net buyback yield (TTM)
- 2.07%
- Shareholder yield
- 2.34%
- Share count change, 1 year
- -1.9%
- Share count change, 3-year CAGR
- -1.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 27, 2026 (filed Jul 31, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 12
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +4.0%
- Average 2-day reaction, last 8
- +1.5%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $631.42
- Target vs current price
- -3.6%
- Analysts with a rating
- 43
- Share rating Buy or Strong Buy
- 84%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 23, 2026 | +5.4% | +8.7% | +9.5% | +16.5% | — |
| Apr 23, 2026 | +3.6% | -9.2% | -9.3% | -12.1% | +2.4% |
| Jan 29, 2026 | +1.9% | -2.6% | -7.0% | -14.5% | -22.7% |
| Oct 22, 2025 | +5.3% | +1.7% | -0.1% | +3.2% | +10.9% |
| Jul 23, 2025 | +2.5% | +9.1% | +12.8% | +16.5% | +23.4% |
| Apr 23, 2025 | +1.0% | -0.7% | -1.7% | -4.8% | -4.6% |
| Jan 30, 2025 | +2.7% | +6.8% | +2.5% | -7.9% | -25.3% |
| Oct 23, 2024 | +0.6% | -1.7% | -6.6% | -13.2% | -2.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 23, 2026 | $6.03 | $5.72 | +5.4% | $11.99B |
| Apr 23, 2026 | $5.44 | $5.25 | +3.6% | $11.01B |
| Jan 29, 2026 | $6.57 | $6.45 | +1.9% | $12.21B |
| Oct 22, 2025 | $5.79 | $5.50 | +5.3% | $11.12B |
| Jul 23, 2025 | $5.36 | $5.23 | +2.5% | $10.86B |
| Apr 23, 2025 | $5.15 | $5.10 | +1.0% | $10.36B |
| Jan 30, 2025 | $6.10 | $5.94 | +2.7% | $11.39B |
| Oct 23, 2024 | $5.28 | $5.25 | +0.6% | $10.60B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 35.2× | 30.9× | 76th | Top 19% |
| P/E (forward) | 26.1× | — | — | — |
| EV / EBITDA | 25.7× | — | — | Top 27% |
| EV / Sales | 6.06× | — | — | Bottom 43% |
| Free-cash-flow yield | 3.02% | — | — | Top 26% |
| Earnings yield | 2.84% | — | — | Top 19% |
P/E over the past five years
Range 24.9× – 38.2× since Jul 3, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +23.4%
- Earnings per share growth (TTM)
- +7.6%
- Change in P/E multiple
- +15.3%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 71
- Days above the 200-day average
- 51
- 50-day average slope (20 days)
- +8.6%
- 200-day average slope (20 days)
- +1.3%
- Distance from 50-day average
- +6.0%
- Distance from 200-day average
- +20.7%
- RSI (14)
- 56.6
- Relative volume
- 0.72×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 28.3%
- Volatility vs own 5-year history
- 62th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.74
- Correlation with S&P 500
- 0.34
- Current drawdown from 1-year high
- -3.7%
- Maximum drawdown, 3 years
- -37.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 31, 2021 | Jun 17, 2025 | -41.5% | 867 days | 319 days (Sep 24, 2026) |
| Nov 6, 2020 | Nov 24, 2020 | -16.7% | 12 days | 165 days (Jul 23, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $242.11B
- P/E (TTM)
- 35.2
- EPS, diluted (TTM)
- $18.59
- Revenue (TTM)
- $46.34B
- Dividend yield
- 0.28%
- 52-week range
- $435.27 – $683.63
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $39.21B | $44.91B | $42.86B | $42.88B | $44.56B |
| Gross profit | $19.63B | $19.01B | $17.19B | $17.73B | $18.24B |
| Operating income | $10.32B | $8.53B | $7.45B | $7.66B | $8.11B |
| Net income | $7.72B | $6.95B | $6.00B | $6.33B | $6.74B |
| EPS (diluted) | $19.46 | $17.64 | $15.45 | $16.53 | $17.74 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.60B | $11.39B | $10.36B | $10.85B | $11.12B | $12.21B | $11.01B | $11.99B |
| Net income | $1.63B | $1.83B | $1.51B | $1.62B | $1.62B | $1.98B | $1.65B | $1.74B |
| EPS (diluted) | $4.24 | $4.78 | $3.98 | $4.28 | $4.27 | $5.21 | $4.43 | $4.68 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $9.54B | $9.15B | $8.41B | $8.67B | $7.82B |
| Capital expenditure | -$2.52B | -$2.24B | -$1.48B | -$1.40B | -$1.52B |
| Free cash flow | $7.02B | $6.91B | $6.93B | $7.27B | $6.29B |
| Dividends paid | -$395.0M | -$455.0M | -$523.0M | -$583.0M | -$636.0M |
| Net share buybacks | -$2.00B | -$3.00B | -$3.00B | -$4.00B | -$3.00B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $4.06B
- Total assets
- $113.17B
- Total liabilities
- $60.49B
- Total debt
- $42.55B
- Net debt
- $38.48B
- Shareholders’ equity
- $52.68B
As of Jun 27, 2026 (filed Jul 31, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 15, 2026 | $0.47 | Oct 15, 2026 |
| Jun 15, 2026 | $0.47 | Jul 15, 2026 |
| Mar 13, 2026 | $0.47 | Apr 15, 2026 |
| Dec 15, 2025 | $0.43 | Jan 15, 2026 |
| Sep 15, 2025 | $0.43 | Oct 15, 2025 |
| Jun 13, 2025 | $0.43 | Jul 15, 2025 |
| Mar 14, 2025 | $0.43 | Apr 15, 2025 |
| Dec 13, 2024 | $0.39 | Jan 15, 2025 |
Short interest
- Shares sold short
- 5,019,933
- Days to cover
- 2.74
- Change vs previous report
- -11.8%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 6, 1996
- 3-for-2
- May 25, 1995
- 3-for-2
- Oct 29, 1993
- 3-for-2
- Nov 3, 1986
- 3-for-2
- Sep 17, 1985
- 3-for-2